[ACRX] YoY Quarter Result on 31-Mar-2018 [#Q1]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
09-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- -17.27%
YoY- 25.46%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Revenue 511 386 265 343 3,109 3,025 181 18.86%
PBT -8,956 -15,925 -13,674 -11,592 -15,551 -10,979 -10,026 -1.86%
Tax 858 843 627 136 -2,704 2 806 1.04%
NP -8,956 -15,925 -13,674 -11,592 -15,551 -10,981 -10,026 -1.86%
Tax Rate - - - - - - - -
Total Cost 9,467 16,311 13,939 11,935 18,660 14,006 10,207 -1.24%
Ratio Analysis
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
NP Margin -1,752.64 -4,125.65 -5,160.00 -3,379.59 -500.19 -363.01 -5,539.23 -17.43%
Per Share
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
EPS -1.58 -3.98 -3.47 -4.55 -6.86 -4.85 -4.57 -16.20%
EPS Diluted -1.58 -3.98 -3.47 -4.55 -6.86 -4.85 -4.51 -16.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.